PTHLH and breast carcinoma: Single-cell metabolomics reveals that breast cancer bone metastases activate osteolytic destruction via parathyroid hormone-related protein (PTHrP)-induced transforming growth factor beta (TGF-β)/calcium signaling, concurrently increasing glycolytic demands [8].